SOUTH SAN FRANCISCO, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its ...

Under the agreement, the two parties will collaborate on research and development, production, clinical trials of new drugs ...

The study aims to test the immunogenicity, efficacy, and safety of OVX836 in shielding individuals from influenza infections.

Alteogen Inc. (KOSDAQ:196170) announced today that the European Commission (EC) has granted marketing authorization for EYLUXVI® (code name: ALT-L9), an Eylea® biosimilar co-developed by its ...

For decades, cancer has been spoken of in hushed tones across the world, a death sentence for millions, especially in regions ...

It has been suggested that, for Korea's regional bio clusters to attain global competitiveness, there is a need for a national-level platform that ...

AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced the completion of enrollment for REGENERATE MSA-101, its Phase 1 ...